Pulmonary Surfactants—Current Status

References

• Basic research on lung surfactant. Progress in respiration research, H Herzog. Karger, Basel 1990; Vol 25: 1–360
   Google Scholar
• Hawgood S, Benson B J. The molecular biology of surfactant apoproteins. Lung cell biology, D Massaro. Dekker, New York 1989; 701–34
   Google Scholar
• Jacobs K A., Phelps D S., Steinbrink R, et al. Isolation of cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem 1987; 262: 9808–11
   PubMed Web of Science ®Google Scholar
• Warr R G., Hawgood S, Buckley D I., et al. Low molecular weight human pulmonary surfactant protein (SP-5): isolation, characterization, and cDNA and amino acid sequences. Proc Natl Acad Sci USA 1987; 84: 7915–9
   PubMed Web of Science ®Google Scholar
• White R T., Damm D, Miller J, et al. Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature (London) 1985; 317: 361–3
   PubMed Web of Science ®Google Scholar
• Tenner A J., Robinson S L., Borchelt J, Wright J R. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR-and CR1-mediated phagocytosis. J Biol Chem 1989; 264: 13923–8
   PubMed Web of Science ®Google Scholar
• Sastry K, Herman G A., Day L, et al. Human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989; 170: 1175–89
   PubMed Web of Science ®Google Scholar
• Revak S, Merritt T A., Degnyse E, et al. Use of human low molecular weight (LMW) apoproteins in the reconstitution of surfactant biologic activity. J Clin Invest 1988; 171: 207–12
   Google Scholar
• Kuroki Y, Mason R J., Voelker D R. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc Natl Acad Sci, USA 1988; 85: 5566–70
   PubMed Web of Science ®Google Scholar
• Rice W R., Ross G F., Singleton F M., Dingle S, Whittsett J A. Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol 1987; 63: 692–8
   PubMed Web of Science ®Google Scholar
• Wright J R., Clements J A. Metabolism and turnover of lung surfactant. Am Rev Respir Dis 1987; 135: 426–44
   PubMed Web of Science ®Google Scholar
• Van Iwaarden F, Welmers B, Verhoef J, Haagsman H P., Van Golde L MG. Pulmonary surfactant protein A enhances host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990; 2: 91–8
   PubMed Web of Science ®Google Scholar
• Rooney S A. Surfactant system and lung phospholipid biochemistry. Am Rev Respir Dis 1985; 131: 439–60
   PubMed Web of Science ®Google Scholar
• Batenburg J J., Hallman M. Developmental biochemistry of alveoli. Pulmonary physiology: Fetus, newborn, child, and adolescent, E M. Scarpelli. Lea Febiger, Philadelphia 1990; 106–39
   Google Scholar
• Boggaram V, Smith M E., Mendelson C R. Regulation of expression of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro. J Biol Chem 1989; 264: 11421–7
   PubMed Web of Science ®Google Scholar
• Ballard P L., Liley H G., Gonzales L W., et al. Interferongamma and synthesis of surfactant components by cultured human fetal lung. Am J Respir Cell Mol Biol 1990; 2: 137–43
   PubMed Web of Science ®Google Scholar
• Coustan D R. Clinical aspects of antenatal enhancement of pulmonary maturation. Clin Perinatol 1987; 14: 697–712
   PubMed Web of Science ®Google Scholar
• Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987; 1256–75
   PubMedGoogle Scholar
• Merritt T A., Hallman M, Spragg R, Held G P., Gilliard N. Exogenous surfactant treatment for neonatal respiratory distress syndrome and their potential role in adult respiratory distress syndrome. Drugs 1989; 38: 591–611
   PubMed Web of Science ®Google Scholar
• Ten centre study group. Ten centre trial of artificial surfactant in very premature babies. Br Med J 1987; 294: 991–6
   PubMed Web of Science ®Google Scholar
• U.S. Exosurf Pediatric Study Group. Effects of two doses of Exosurf R Pediatric in 419 700–1350 gram infants. Pediatr Res 1990; 27: 228A
   Web of Science ®Google Scholar
• Hallman M. Recycling of surfactant: A review of human amniotic fluid as a source of surfactant for treatment of respiratory distress syndrome. Rev Perinat Med 1989; 6: 197–226
   Google Scholar
• Collaborative European Multicentre Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized, clinical trial. Pediatrics 1988; 319: 683–91
   Google Scholar
• Hallman M, Merritt T A., Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: Evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986; 20: 1228–35
   PubMed Web of Science ®Google Scholar